Spitalul Universitar De Urgenta Bucuresti
- Address
- lock Available on a paid plan
Cardiovascular Diseases and Heart Research at Spitalul Universitar De Urgenta Bucuresti
Clinical trials at this site focus strongly on cardiovascular diseases, especially conditions that raise the risk of heart attack, stroke, and heart failure. The research is aimed at testing new therapies and improving prevention strategies for people with high-risk heart and blood vessel disorders.
- Acute coronary syndrome and recurrent cardiovascular event prevention
- Atrial fibrillation, including stroke prevention and bleeding risk reduction
- Heart failure with preserved or mildly reduced ejection fraction and systemic inflammation
- Atherosclerotic cardiovascular disease with elevated lipoprotein(a)
These studies explore whether newer treatments can better protect patients from major cardiovascular complications and improve long-term outcomes.
Oncology and Targeted Cancer Treatment Studies
This site also contributes to neoplasm research, with trials centered on both blood cancers and advanced solid tumors. The main goal is to evaluate treatment effectiveness and safety for patients with difficult-to-treat cancers.
- Isocitrate dehydrogenase 1 mutation-positive acute myeloid leukemia
- Advanced non-small cell lung cancer without PD-L1 expression and with KRAS p.G12C mutation
The research includes studies of newer cancer therapies and combination approaches designed to improve disease control and survival.
Respiratory Tract Diseases in Severe Infection and Lung Cancer Research
Within respiratory tract diseases, clinical trials at the Bucharest hospital examine both serious lung infections and advanced lung cancer. The research is focused on finding better ways to treat severe illness and improve outcomes in hospitalized patients.
- Severe community-acquired pneumonia
- Advanced non-small cell lung cancer
These studies are designed to test new treatment options and support more effective care for patients with major respiratory conditions.
Reproductive and Urinary Physiological Phenomena in Women’s Health Research
Research in reproductive and urinary physiological phenomena includes studies related to pregnancy prevention and contraceptive care. The focus is on assessing whether a new contraceptive option is effective, safe, and acceptable for use.
- Prevention of pregnancy
- Contraceptive efficacy and tolerability
This area reflects practical clinical research aimed at improving family planning options and supporting women’s health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 12 therapeutic areas and 15 of 97 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 93 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 19 by active trials.
- 1Amgen Inc.5active
lock +18 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.7trials
lock +11 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Universitar De Urgenta Bucuresti
lock Showing 1 of 53 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV) | Amgen Inc. | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 97 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cyclophosphamide | 4 | Unknown | 2020-10-12 | 2025-04-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.